Jerome Garin

Title: Jerome Garin: Innovator in Cancer Diagnosis

Introduction

Jerome Garin is a notable inventor based in Paris, France. He has made significant contributions to the field of cancer diagnosis through his innovative research and development. His work focuses on the identification of biomarkers that can aid in the early detection and prognosis of bladder cancer.

Latest Patents

Garin holds a patent for "Bladder cancer biomarker proteins." This invention relates to a collection of signature peptides representing at least 10 proteins for use in cancer diagnosis and/or prognosis. It includes an artificial protein comprising these signature peptides and a nucleic acid construct encoding for such an artificial protein. Additionally, the invention outlines a method for cancer diagnosis and/or prognosis that involves analyzing at least 10 proteins in a urine sample from a subject. Furthermore, it encompasses an immunoassay product that includes antibodies for detecting at least 10 proteins.

Career Highlights

Throughout his career, Jerome Garin has worked with various organizations, including Polyquant GmbH and Commissariat à l'Énergie Atomique et aux Énergies Alternatives. His experience in these companies has contributed to his expertise in the field of biomarker research and cancer diagnostics.

Collaborations

Garin has collaborated with notable professionals in his field, including Christophe Masselon and Antonia Vlahou. These collaborations have further enhanced his research and development efforts in cancer diagnosis.

Conclusion

Jerome Garin's innovative work in the field of cancer diagnosis, particularly through his patented biomarker proteins, showcases his commitment to advancing medical science. His contributions are vital for improving cancer detection and prognosis, ultimately benefiting patients worldwide.